Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Genetic Control of Programmed Cell Death in C. Elegans

Loading video...

Air date: Monday, January 22, 2007, 12:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 103 * This only includes stats from October 2011 and forward.
Category: Neuroscience
Runtime: 01:10:08
Description: Dr. Horvitz received the Nobel Prize in Physiology or Medicine in 2002. He is the David Koch Professor of Biology at MIT; an Investigator of Howard Hughes Medical Institute; Neurobiologist (Neurology) and Geneticist (Medicine) at Massachusetts General Hospital; and Member of the McGovern Institute for Brain Research and MIT Center for Cancer Research. He has served on many editorial boards, visiting committees and advisory committees. He has been a consultant to a number of pharmaceuticals and was cofounder of the biotechnology companies NemaPharm, Inc. and Idun Pharmaceuticals. He received an Honorary M.D. from the University of Rome (2004), and Honarary D.Sc. from Cambridge University (2004) and an Honorary D.Sc. from Pennsylvania State University (2006).

http://mit.edu/biology/www/facultyareas/facresearch/horvitz.shtml

Neuroscience Seminar
NLM Title: Genetic control of programmed cell death in C. elegans / Bob Horvitz.
Author: Horvitz, H Robert.
National Institutes of Health (U.S.)
Publisher:
Abstract: (CIT): Dr. Horvitz received the Nobel Prize in Physiology or Medicine in 2002. He is the David Koch Professor of Biology at MIT; an Investigator of Howard Hughes Medical Institute; Neurobiologist (Neurology) and Geneticist (Medicine) at Massachusetts General Hospital; and Member of the McGovern Institute for Brain Research and MIT Center for Cancer Research. He has served on many editorial boards, visiting committees and advisory committees. He has been a consultant to a number of pharmaceuticals and was cofounder of the biotechnology companies NemaPharm, Inc. and Idun Pharmaceuticals. He received an Honorary M.D. from the University of Rome (2004), and Honarary D.Sc. from Cambridge University (2004) and an Honorary D.Sc. from Pennsylvania State University (2006).
Subjects: Apoptosis--genetics
Caenorhabditis elegans--genetics
Publication Types: Lecture
Webcast
NLM Classification: QU 375
NLM ID: 101298624
CIT Live ID: 5231
Permanent link: https://videocast.nih.gov/watch=5231

The server returned an invalid or unrecognized response